Stock MEDIVATION INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Medivation Inc

Equities

US58501N1019

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Medivation Inc
2016 Eli Lilly and : Drugmaker Sanofi hungry for deals after earnings beat RE
2016 Exclusive - GW Pharmaceuticals hires investment bank following approaches: sources RE

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Medivation : New Data Presented at ESMO 2016 Further Demonstrates XTANDITM▼ (enzalutamide) Significantly Improves Time to PSA Progression in Advanced Prostate Cancer, Compared with Placebo
BU
Brower Piven Commences An Investigation Into The Proposed Sale Of Medivation, Inc. And Encourages Shareholders To Contact The Firm For Additional Information
BU
Brower Piven Commences An Investigation Into The Proposed Sale Of Medivation, Inc. And Encourages Investors To Contact The Firm For Additional Information
BU
REMINDER: Medivation to Host Conference Call and Webcast Providing Detailed Review of Talazoparib on July 6, 2016
BU
Medivation : Enters into Confidentiality Agreements, Including with Sanofi
BU
Medivation : Glass Lewis Recommends Medivation's Stockholders Support the Company's Current Board
PU
Medivation : Glass Lewis Recommends Medivation’s Stockholders Support the Company’s Current Board
BU
Medivation : Sends Letter to Stockholders to Set the Record Straight on Sanofi's Misleading Claims
PU
Medivation : Sends Letter to Stockholders to Set the Record Straight on Sanofi’s Misleading Claims
BU
Medivation : Files Definitive Consent Revocation Statement and Mails Letter to Stockholders
BU
Medivation : Sets Record Date for Sanofi's Proposed Consent Solicitation
PU
Medivation : Sets Record Date for Sanofi’s Proposed Consent Solicitation
BU
Medivation : Files Preliminary Consent Revocation Statement
BU
Medivation : Urges Stockholders to Reject Sanofi's Attempt to Replace Medivation Board of Directors
PU
Medivation : Urges Stockholders to Reject Sanofi’s Attempt to Replace Medivation Board of Directors
BU
Medivation : Reiterates Rejection of Sanofi's Substantially Inadequate Proposal
BU
Medivation : CHMP Issues Positive Opinion to Include New Data in European Label for XTANDI(R) (enzalutamide)
PR
Medivation : Jennifer Jarrett to Join Medivation as Chief Financial Officer
MW
Medivation : Pivotal Phase III Trial of Enzalutamide Initiated in Metastatic Hormone Sensitive Prostate Cancer
MW
Medivation : U.S. FDA Lifts Partial Clinical Hold on Medivation's Pidilizumab
MW
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Medivation Inc
  5. Press Releases